-+ 0.00%
-+ 0.00%
-+ 0.00%

Greenwich LifeSciences Shares Up After European Approval for Use of GP2 in Breast Cancer Immunotherapy Trial

Dow Jones·07/09/2026 14:28:00

Please log in to view news